Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PRO MEDICUS LIMITED Director's Dealing 2010

Sep 15, 2010

65579_rns_2010-09-15_6ffe9760-a146-47b8-ac7a-a3f0222d94c1.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Rule 3.19A.2

Appendix 3Y

Change of Director's Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 30/9/2001.

Name of entity Pro Medicus Limited
ABN 25 006 194 752

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Peter Terence KEMPEN
Date of last notice 2 March 2010

Part 1 - Change of director's relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.

Direct or indirect interest Indirect
Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to the relevantinterest. Ordinary fully paid shares in Pro MedicusLimitedheldbytheElaineKempenSuperannuation Fund of which the Director isa Trustee and Member
Date of change 15 September 2010
No. of securities held prior to change 129,647
Class Ordinary shares
Number acquired 40,000
Number disposed Nil
Value/ConsiderationNote: If consideration is non-cash, provide details and estimatedvaluation $0.4966 cents per share for 40,000 shares
No. of securities held after change 169,647 ordinary shares

+ See chapter 19 for defined terms.

Nature of changeExample: on-market trade, off-market trade, exercise of options, issue ofsecurities under dividend reinvestment plan, participation in buy-back On market purchase

Part 2 – Change of director's interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be disclosed in this part.

Detail of contract N/A
Nature of interest N/A
Name of registered holder(if issued securities) N/A
Date of change N/A
No. and class of securities towhich interest related prior tochangeNote: Details are only required for a contract in relationto which the interest has changed N/A
Interest acquired N/A
Interest disposed N/A
Value/ConsiderationNote: If consideration is non-cash, provide details andan estimated valuation N/A
Interest after change N/A

For and on behalf of Pro Medicus Limited

Clayton Hatch Company Secretary 16 September 2010

+ See chapter 19 for defined terms.